Endotypes in allergic diseases

Purpose of review The precision medicine concept is both appealing and challenging. We review here the recent findings in the endotype-driven approach for major allergic diseases. Recent findings Stratified medicine for different allergic diseases can identify patients who are more likely to benefit or experience an adverse reaction in response to a given therapy and anticipate their long-term outcome and vital risk. In addition, this approach potentially facilitates drug development and prevention strategies. Summary The endotype-driven approach in allergic diseases has tremendous potential, but there are notable barriers in reaching the new world of precision medicine. Multidimensional endotyping integrating visible properties with multiple biomarkers is recommended for both type 2 and nontype 2 allergic diseases to provide evidence that a certain pathway is the key driver for a given patient. Significant healthcare system changes are required to achieve the expected targets. Correspondence to Ioana Agache, Faculty of Medicine, Transylvania University, Theramed Healthcare, Pictor Ion Andreescu 2A, 50051, Brasov, Romania. Tel: +40 728 878386; e-mail: ibrumaru@unitbv.ro Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.

http://ift.tt/2HPQ5Hz